Aegis Lifesciences happy to share their presence at Hospitalar 2022

  As we unite to commemorate  World Cancer Day 2025  under the theme  “United by Uniqueness” , it’s a moment to reflect on the strides being made in cancer care and the collective efforts required to combat this global health challenge. This year’s theme emphasizes the diversity of cancer care and the importance of innovation in addressing unique patient needs. At the forefront of these advancements are groundbreaking surgical techniques and supportive tools, such as hemostatic agents, which play a vital role in improving outcomes for cancer patients worldwide. Challenges in Oncological Surgeries Oncological surgeries are among the most intricate and high-risk medical procedures. The complexity arises from the need to remove tumors while minimizing damage to surrounding tissues and managing potential complications, such as excessive bleeding. Bleeding, particularly in highly vascularized areas like the breast, liver, pancreas, and lungs, remains one of the most criti...

  Total Knee Arthroplasty (TKA) is an effective solution for advanced knee osteoarthritis, providing pain relief and improved mobility. However, significant perioperative blood loss remains a major challenge, potentially delaying recovery and increasing complications [1].   Oxidized Regenerated Cellulose (ORC) powder  is an advanced, absorbable hemostatic agent that effectively controls bleeding, addressing this critical concern during TKA procedures. This blog delves into the challenges posed by blood loss in TKA, the limitations of traditional hemostatic materials, and the transformative role of modern agents like ORC powder, providing a comprehensive understanding of how they contribute to better surgical outcomes. Challenges in TKA Surgeries TKA procedures typically involve extensive exposure of cancellous bone and soft tissues, with the use of tourniquets contributing to both intraoperative and hidden blood loss. This blood loss can lead to postoperative anaemia, pro...